Stay updated on IBI310 Combo vs Sorafenib in HCC Clinical Trial

Sign up to get notified when there's something new on the IBI310 Combo vs Sorafenib in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IBI310 Combo vs Sorafenib in HCC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page's revision tag moved from v3.5.3 to v3.5.4, indicating a new version of the record history. This reflects an update to the page's metadata rather than changes to the underlying study data.
    Difference
    0.1%
    Check dated 2026-05-14T22:55:14.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The Record History shows the latest revision updated to v3.5.3, replacing the previous v3.5.2. This indicates a new version of the study record has been published.
    Difference
    0.1%
    Check dated 2026-04-30T17:31:15.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added to the record history, and revision v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-16T10:40:06.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision v3.5.0 adds Study Status, Contacts/Locations, and Study Design and marks the study as Completed; the prior update removed the Recruiting status and sponsor Innovent Biologics (Suzhou) Co. Ltd.
    Difference
    2%
    Check dated 2026-03-25T20:54:51.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The record history now includes revision v3.4.3 and removes v3.4.2 from the history.
    Difference
    0.1%
    Check dated 2026-03-11T16:46:57.000Z thumbnail image
  9. Check
    109 days ago
    Change Detected
    Summary
    The history page adds Revision: v3.4.2 and removes the government funding notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2026-02-11T02:24:05.000Z thumbnail image

Stay in the know with updates to IBI310 Combo vs Sorafenib in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IBI310 Combo vs Sorafenib in HCC Clinical Trial page.